The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: Evidence to be considered when screening children for tuberculosis infection

Thorax

Volumn 71, Issue 10, 2016, Pages 932-939

  Seddon, James A ^a   Paton, James ^b   Nademi, Zohreh ^c,d   Keane, Denis ^a   Williams, Bhanu ^e   Williams, Amanda ^e   Welch, Steven B ^f   Liebeschutz, Sue ^g   Riddell, Anna ^h   Bernatoniene, Jolanta ⁱ   Patel, Sanjay ^j   Martinez Alier, Nuria ^k   McMaster, Paddy ^l   Kampmann, Beate ^a,m  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e EALING HOSPITAL NHS TRUST   (United Kingdom)

^f UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^g NEWHAM UNIVERSITY HOSPITAL   (United Kingdom)

^h ROYAL LONDON HOSPITAL   (United Kingdom)

ⁱ BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^j SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^k EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^l NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^m Medical Research Council Unit   (Gambia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULIN;

ADOLESCENT; AGE; ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HOUSEHOLD; HUMAN; INFANT; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; POPULATION EXPOSURE; PREDICTION; PREDICTIVE VALUE; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; TUBERCULIN TEST; TUBERCULOSIS; UNITED KINGDOM; AGING; CLINICAL TRIAL; EVALUATION STUDY; EVIDENCE BASED MEDICINE; IMMUNOLOGY; MASS SCREENING; MULTICENTER STUDY; PROCEDURES; VACCINATION;

ADOLESCENT; AGING; BCG VACCINE; CHILD; CHILD, PRESCHOOL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA RELEASE TESTS; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION;

EID: 84978969892     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-207687     Document Type: Article

References (29)

1. Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 2008;8:359-68.
2. Basu Roy R, Whittaker E, Kampmann B. Current understanding of the immune response to tuberculosis in children. Curr Opin Infect Dis 2012;25:250-7.
3. Jones C, Whittaker E, Bamford A, et al. Immunology and pathogenesis of childhood TB. Paediatr Respir Rev 2011;12:3-8.
4. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:392-402.
5. Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009;48:108-14.
6. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970;26:28-106.
7. Akolo C, Adetifa I, Shepperd S, et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010;(1):CD000171.
8. Smieja MJ, Marchetti CA, Cook DJ, et al. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000;(2):CD001363.
9. Enarson DA. Use of the tuberculin skin test in children. Paediatr Respir Rev 2004;5 (Suppl A):S135-7.
10. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011;30:694-700.
11. Public Health England. The Green Book: Immunisation against infectious disease. 2013. https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book (accessed 5 Jun 2015).
12. National Institute for Health and Care Excellence. Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2006.
13. Watkins RE, Brennan R, Plant AJ. Tuberculin reactivity and the risk of tuberculosis: a review. Int J Tuberc Lung Dis 2000;4:895-903.
14. World Health Organization. Guidance for national tuberculosis programme on the management of tuberculosis in children (second edition). Geneva, Switzerland. 2014. http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748-eng.pdf?ua=1 (accessed 29 May 2014).
15. National Institute for Health and Care Excellence. Tuberculosis. 2016. http://www.nice.org.uk/guidance/ng33/resources/tuberculosis-prevention-diagnosis-managementand-service-organisation-1837390683589 (accessed 18 Jan 2016).
16. Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-204.
17. Piñeiro R, Mellado MJ, Cilleruelo MJ, et al. Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results? Eur J Pediatr 2012;171:1625-32.
18. Reid JK, Ward H, Marciniuk D, et al. The effect of neonatal bacille Calmette-Guérin vaccination on purified protein derivative skin test results in Canadian aboriginal children. Chest 2007;131:1806-10.
19. Berti E, Galli L, Venturini E, et al. Tuberculosis in childhood: a systematic review of national and international guidelines. BMC Infect Dis 2014;14(Suppl 1):S3.
20. Chiappini E, Accetta G, Bonsignori F, et al. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis. Int J Immunopathol Pharmacol 2012;25:557-64.
21. Bamford AR, Crook AM, Clark JE, et al. Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child 2010;95:180-6.
22. Mandalakas AM, Detjen AK, Hesseling AC, et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011;15:1018-32.
23. World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. (WHO/HTM/TB/2012.9). Geneva, Switzerland. 2012 http://apps.who.int/iris/bitstream/10665/77741/1/9789241504492-eng.pdf?ua=1 (accessed 29 Jul 2015).
24. Frydenberg AR, Graham SM. Toxicity of first-line drugs for treatment of tuberculosis in children: review. Trop Med Int Health 2009;14:1329-37.
25. Gray DM, Zar H, Cotton M. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Cochrane Database Syst Rev 2009;(1):CD006418.
26. Bright-Thomas R, Nandwani S, Smith J, et al. Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children. Arch Dis Child 2010;95:600-2.
27. Mandalakas AM, Hesseling AC, Gie RP, et al. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax 2013;68:247-55.
28. Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011;365: 2155-66.
29. Villarino ME, Scott NA, Weis SE, et al. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr 2015;169:247-55.